TCW Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-11,904
| Closed | -$837K | – | 569 |
|
|
2016
Q4 | $837K | Sell |
11,904
-135
| -1% | -$9.49K | 0.01% | 529 |
|
|
2016
Q3 | $854K | Sell |
12,039
-4,414
| -27% | -$313K | 0.01% | 514 |
|
|
2016
Q2 | $804K | Buy |
16,453
+3,989
| +32% | +$195K | 0.01% | 529 |
|
|
2016
Q1 | $789K | Sell |
12,464
-2,595
| -17% | -$164K | 0.01% | 542 |
|
|
2015
Q4 | $1.69M | Sell |
15,059
-61
| -0.4% | -$6.85K | 0.01% | 392 |
|
|
2015
Q3 | $1.46M | Sell |
15,120
-8,114
| -35% | -$781K | 0.01% | 427 |
|
|
2015
Q2 | $2.38M | Sell |
23,234
-8,152
| -26% | -$835K | 0.02% | 356 |
|
|
2015
Q1 | $1.95M | Sell |
31,386
-6,287
| -17% | -$390K | 0.01% | 631 |
|
|
2014
Q4 | $1.65M | Sell |
37,673
-10,009
| -21% | -$439K | 0.01% | 643 |
|
|
2014
Q3 | $2.7M | Sell |
47,682
-4,225
| -8% | -$239K | 0.01% | 622 |
|
|
2014
Q2 | $2.33M | Buy |
51,907
+27,720
| +115% | +$1.24M | 0.01% | 650 |
|
|
2014
Q1 | $1.18M | Buy |
+24,187
| New | +$1.18M | ﹤0.01% | 704 |
|